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AbstrACt
Objective This study aimed to analyse the impact of 
comprehensive smoke-free legislation (SFL) on the 
prevalence and incidence of adult smoking in primary 
healthcare (PHC) patients from three Spanish regions, 
overall and stratified by sex.
Design Longitudinal observational study conducted 
between 2008 and 2013.
setting 66 PHC teams in Catalonia, Navarre and the 
Balearic Islands (Spain).
Participants Population over 15 years of age assigned to 
PHC teams.
Primary and secondary outcomes measures Quarterly 
age-standardised prevalence of non-smoker, smoker 
and ex-smoker and incidence of new smoker, new ex-
smoker and ex-smoker relapse rates were estimated 
with data retrieved from PHC electronic health records. 
Joinpoint analysis was used to analyse the trends of age-
standardised prevalence and incidence rates. Trends were 
expressed as annual percentage change and average 
annual percent change.
results The overall standardised smoker prevalence rate 
showed a significant downward trend (higher in men than 
women) and the overall standardised ex-smoker prevalence 
rate showed a significant increased trend (higher in women 
than men) in the three regions. Standardised smoker and 
ex-smoker prevalence rates were higher for men than women 
in all regions. With regard to overall trends of incidence rates, 
new smokers decreased significantly in Catalonia and Navarre 
and similarly in men and women, new ex-smokers decreased 
significantly and more in men in Catalonia and the Balearic 
Islands, and ex-smoker relapse increased in Catalonia 
(particularly in women) and decreased in Navarre.
Conclusions Trends in smoking behaviour in PHC patients 
remain unchanged after the implementation of comprehensive 
SFL. The impact of the comprehensive SFL might have been 
lessened by the effect of the preceding partial SFL.
IntrODuCtIOn   
Smoking is the leading worldwide cause of 
preventable death.1 According to WHO, it 
is estimated that at least 30 million people 
may die prematurely from tobacco-re-
lated diseases.2 Legislative measures have 
been adopted to protect people’s health in 
public areas and workplaces. These include 
increasing the price of cigarettes, banning 
advertising, sponsorship and smoking in 
workplaces and public spaces, displaying 
warnings on tobacco packets and imple-
menting prevention programmes.3 
Some studies show a decrease in smoking 
prevalence since the introduction of smoke-
free legislation (SFL).4–9 A meta-analysis of 
26 studies on the effect of the smoke-free 
workplace in various countries concluded 
in 2002 that smoke- free workplaces protect 
non-smokers from the dangers of passive 
smoking, and they encourage smokers to 
reduce tobacco consumption. The authors 
concluded that SFL is associated with a 
strengths and limitations of this study
 ► To our knowledge, no studies have been pub-
lished on the impact of the Spanish comprehensive 
smoke-free legislation in all adult primary health-
care patients.
 ► Used as a research tool, electronic health records 
portray real life conditions and provide comprehen-
sive, long-term health histories from a large popu-
lation sample.
 ► The results of quarterly data by Joinpoint analysis 
provides more precise information than an analysis 
before-after the implementation of the law.
 ► This study only considered age and sex since oth-
er variables were not available for the adjusted 
analysis.
 ► The study period started later (shorter follow-up) in 
the Balearic Islands to ensure reliability of data.
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3%–4% reduction in tobacco consumption.10 In contrast, 
a Cochrane review published in 2016, which included 24 
studies on smoking behaviour, showed inconsistencies 
regarding the impact of smoking bans on smoking preva-
lence and tobacco consumption.11
On 1 January 2006, the Spanish government intro-
duced a partial SFL (Law 28/2005),12 which included 
regulations on the sale, supply, consumption and adver-
tising of tobacco products. Smoking was banned at all 
indoor public and private workplaces with the exception 
of the hospitality sector, where partial restrictions were 
established depending on the size of the establishment, 
that is, in bars or restaurants smaller than 100 m2 the 
managers could decide whether to allow smoking in the 
premises (Law 28/2005). The mean concentration of 
nicotine subsequently decreased by 60% in public admin-
istration offices and by 97.4% in private workplaces, but 
in areas where smoking was permitted, including bars and 
nightclubs, no changes were found.13–15 This prompted 
the enactment of comprehensive SFL (Law 42/2010),16 
which came into force in January 2011. This comprehen-
sive law expanded smoking restriction to all hospitality 
venues of any size and, as a result, smoking was forbidden 
in all enclosed public places, including bars, restaurants 
and nightclubs, and in some open-air public places such 
as playgrounds.
Some studies have analysed the impact of these two 
Spanish laws on smoking prevalence. However, most 
have been based on health surveys13 17–20 and surveys of 
hospitality workers.21 22 Moreover, some studies evaluate 
only the partial law,13 17 18 whereas others analyse the 
compound impact of both laws.19 20 23 24 The results of 
these studies are often conflicting; while some conclude 
that the partial SFL does not have any effect on the down-
ward trend in the prevalence of smokers,13 19 23 other 
studies show a reduction in smoking prevalence,24 an 
increase of the smoking quit ratio in the short term18 and 
minor increases in the prevalence of active smoking.20
Only one study conducted in PHC patients evaluates 
the impact of the Spanish partial SFL, including smoking 
prevalence in active smoker workers that attended PHC 
visits; 1 month after the implementation of the law, a 9.5% 
decline of smokers was observed.25 To our knowledge, no 
studies have been published on the impact of the Spanish 
comprehensive SFL in all adult PHC patients. In view of 
the pivotal role of PHC services in smoking habits, we 
consider that the information registered in PHC records 
is a good proxy to generate up-to-date evidence and to 
evaluate the impact of comprehensive SFL in the general 
population.
We hypothesised that Law 42/2010 does reduce expo-
sure to environmental cigarette smoke and its harmful 
effects and crucially, it promotes smoking denormali-
sation in society, thus encouraging smokers to quit or 
reduce consumption and discouraging non-smokers from 
initiating this habit. Accordingly, the aim of this study was 
to examine the impact of the Spanish comprehensive SFL 
(Law 42/2010) on the prevalence and incidence of adult 
smoking in PHC patients in three regions (Catalonia, 
Navarre and Balearic Islands), during the 2008–2013 
period, overall and stratified by sex.
MethODs
Design, study participants and information source
Longitudinal observational study of the adult popula-
tion assigned to 66 PHC teams (PHCTs) in three Spanish 
regions: Catalonia, Navarre and the Balearic Islands (22 
PHCTs per region). Inclusion criteria of the PHCTs were: 
(1) Computerisation of electronic health records (EHRs) 
by 1 January 2005 in Catalonia and Navarre, and 2008 
in the Balearic Islands. (2) Agreement to participate in 
the study by over 80% healthcare professionals working 
in each PHCT. Random cluster sampling was stratified 
by region, with PHCT as randomisation unit.26 In each 
PHCT, general practitioners (GPs) with a patient list 
between 400 and 3000 were selected. GPs with shorter 
patient lists were accepted if it was their first year in the 
PHCT.
The study period included from the first quarter of 2008 
to the fourth quarter of 2013 in Catalonia and Navarre; 
and from the second quarter of 2010 to the fourth quarter 
of 2013 in the Balearic Islands. The study started in 2008 
to obtain data from the 2 years prior analysis, a require-
ment to adequately construct the variable ex-smoker. In 
the case of the Balearic Islands, the study started later to 
ensure reliability of data.
Inclusion criteria for patients were: (1) Population 
allocated to the selected PHCT for the whole 2007–2013 
period in Catalonia and Navarre; in the Balearic Islands, 
patients allocated to the selected PHCT in 2013 and eval-
uated retrospectively (no historical annual comprehen-
sive register of allocation of patients was available). (2) 
Age ≥16 years and ≤100 years in 2007 in Catalonia and 
Navarre, and 2010 in the Balearic Islands. (3) In order to 
have data in the EHR collected during the study period, 
a minimum of one visit to their PHCT during the 2007–
2013 period in Catalonia and Navarre and 2010–2013 in 
the Balearic Islands. (4) Information on smoking habit 
recorded in the EHR for the quarter prior to the onset of 
the study: last quarter of 2007 in Catalonia and Navarre 
and first quarter of 2010 in the Balearic Islands, to enable 
the adequate construction of the various variables. Since 
smoking is not an acute condition, this information was 
considered valid until new information was entered. Thus, 
closed cohorts (with fixed membership, where nobody is 
added nor excluded after the study begins) were consti-
tuted in the three regions. Figure 1 shows the flow chart 
of the study.
Data were retrieved from the Registry of Preventive 
Services in Primary Care (REGIPREV) database,26 which 
contains encrypted and anonymised clinical information 
recorded in the EHR by these 66 PHCTs. An algorithm 
was applied to extract equivalent data from the health 
records software used in each region: ‘ECAP’ in Catalonia, 
‘Atenea’ in Navarre and ‘e-siap’ in the Balearic Islands. 
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Codes of the International Classification of Diseases, 
ninth revision in the Balearic Islands (ICD-9) and tenth 
in Catalonia (ICD tenth revision)27 and the International 
Classification of Primary Care, second edition, in Navarre 
(ICPC-2)28 were used.
Variables
Information on smoking is registered in the EHRs using 
diagnostic codes to classify diseases (codes F17.0 to F17.9 
and Z72.0 of the ICD-10, 305.1 of the ICD-9 and P17 of 
the ICPC-2), and also clinical variables (number of ciga-
rettes per day, history of smoking, history of advice for 
smoking cessation). This information is stored with the 
entry date (online supplementary file table S1). With the 
information on smoking status and entry date we created 
the following dependent variables at the end of each 
quarter of the study period:
Smoking status (three categories): (1) Non-smoker: 
patient that has never been a tobacco consumer. (2) 
Smoker: tobacco consumer or patient that has quit 
smoking for less than 12 months. (3) Ex-smoker: pa-
tient who used to smoke but has quit smoking for at 
least 12 continuous months. When the EHR did not 
Figure 1 Flow chart of patients included in the study, by region. 
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contain a new entry related to smoking status (diag-
nostic codes or clinical variables), we considered that 
no changes in smoking status had taken place and thus 
the last observation was still valid.
New smoker: patient non-smoker for the 12 months 
prior to the considered quarter that has started smok-
ing during the said quarter.
New ex-smoker: the patient was a smoker 2 years before 
the considered quarter and has continuously abstained 
from tobacco for at least 12 months.
Ex-smoker relapse: patient ex-smoker during the 12 
months prior to the considered quarter that has start-
ed smoking again during the said quarter.
For higher accuracy in prevalence and incidence 
changes, quarterly estimates were calculated.
The following variables of each patient were collected 
at baseline (2008 in Catalonia and Navarre; 2010 in 
the Balearic Islands): age, sex (male/female), annual 
number of health problems and annual number of PHC 
visits. The number of health problems was used as a 
morbidity indicator; it was calculated as the sum of the 
number of different active health problems (chronic and 
acute, coded by ICPC-2).
Data analyses
Descriptive statistics were used to summarise overall 
information. Categorical variables were expressed as 
percentage, and continuous variables as mean (SD) or 
median (IQR).
Because the three regions used different EHR systems 
(different standards and computer programs), have 
different socioeconomic characteristics, different 
complementary measures to the SFL and also due to 
the shorter study period in the Balearic Islands, we 
performed a stratified analysis per region, overall and 
by sex. Age-standardised prevalence (non-smokers, 
smokers and ex-smokers) and incidence (new smokers, 
new ex-smokers and ex-smoker relapse) rates were calcu-
lated for each quarter using the direct method, and based 
on the European standard population (rates per 10 000 
inhabitants).
Joinpoint analysis was used to analyse the trends of 
age-standardised prevalence (smokers and ex-smokers) 
and incidence rates (new smokers, new ex-smokers 
and ex-smoker relapse) and to identify the best-fitting 
points (the ‘joinpoints’, in calendar quarters) where 
the rate changes significantly in the linear slope of the 
temporal trend. Significant changes include changes in 
direction or in the rate of increase or decrease.29 Join-
point analysis estimates the magnitude of the increase 
or the decrease observed in each specified time interval 
by estimating the annual percentage change (APC). In 
addition, temporal trends were expressed as the average 
annual percent change (AAPC), computed to summarise 
and compare these trends over the entire time period. 
Because the outcomes originate from repeated measure-
ments, control for the autocorrelation errors was used; 
95% CIs of APC and AAPC were calculated. The trend of 
non-smoker prevalence rates was not calculated because 
the study consisted of a closed cohort where no new 
participants are recruited, and thus the prevalence of 
non-smokers can either remain the same or decrease, but 
never increase.
Analyses were performed using Stata/SE V.14.2 for 
Windows (Stata Corp, College Station, Texas, USA). 
The Joinpoint regression analysis was carried out using 
the Joinpoint software from the Surveillance Research 
Programme of the US National Cancer Institute (ref. 
Joinpoint Regression Program, V.4.6.0. April, 2018; Statis-
tical Research and Applications Branch, National Cancer 
Institute) (https:// surveillance. cancer. gov/ branches/ 
srab/).
Patient and public involvement
Study participants were not involved in the development 
of the research question or the outcome measures, nor 
in the design of the study. The results will be presented 
to citizens through informative activities and the media.
results
The study population was 392 966 patients: 141 071 in 
Catalonia, 73 644 in Navarre and 178 251 in the Balearic 
Islands (figure 1). At the onset of the study, the mean age 
was 50.4 years in Catalonia, 54.0 years in Navarre and 47.7 
years in the Balearic Islands. In the three cohorts more 
than half were women (>51%). Catalonia presented 
the highest median number of visits (9, IQR: 3–16) and 
the Balearic Islands presented the highest number of 
recorded active health problems per patient (median 10, 
IQR: 6–16) (table 1).
The overall standardised smoker prevalence rates per 10 000 
inhabitants were of similar magnitude in the three regions 
(ranges of 3579.2–4138.9 in Catalonia, 3719.8–4034.2 
in Navarre and 3787.4–4029.7 in the Balearic Islands). 
The prevalence rate decreased in Navarre during the 
whole study period, decreased in the Balearic Islands in 
most quarters and also in Catalonia except for the last 
year. These rates were higher for men than for women 
in all regions (online supplementary file table S2–S7). 
A significant downward overall trend of smoker prevalence 
rates was found in Catalonia (AAPC=−2.18), Navarre 
(AAPC=−1.44) and the Balearic Islands (AAPC=−1.75); 
this downward trend was higher for men than for women 
in the three regions. In Catalonia, the most significant 
reduction occurred during the period 2010.3–2011.4 
(APC=−6.75), similarly to the Balearic Islands (2010.2–
2012.4; APC=−2.19), whereas in Navarre it occurred 
between 2008.1 and 2013.4 (APC=−1.44) (tables 2, 3 and 
4, online supplementary file figure S1).
For the whole period, the overall standardised ex-smoker 
prevalence rates per 10 000 inhabitants increased in Navarre, 
in the Balearic Islands and in Catalonia except for the 
last year. The rates in Catalonia were higher (ranges of: 
1168.5–1781.2 in Catalonia; 313.3–764.1 in Navarre; and 
559.3–914.1 in the Balearic Islands). The standardised 
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ex-smoker prevalence rates were higher for men than for 
women in all regions (online supplementary file table S2–
S7). The overall trend of ex-smoker prevalence rates increased 
significantly in the three regions throughout the study 
period but was higher in Navarre (Navarre AAPC=16.67; 
Catalonia AAPC=7.19; Balearic Islands AAPC=14.96). The 
increase in the prevalence rate of ex-smokers was higher 
for the 2008.1–2008.2 period in Catalonia, 2008.1–2008.4 
in Navarre and for 2010.2–2012.2 in the Balearic Islands, 
and higher in women in the three regions (women: Cata-
lonia AAPC=10.87; Navarre AAPC=17.30 and Balearic 
Islands AAPC=19.51) (tables 2, 3 and 4, online supple-
mentary file figure S1).
The overall new smoker standardised incidence rates per 
10 000 inhabitants showed low values in the three regions 
(ranges of 7.9–26.8 in Catalonia; 9.5–30.9 in Navarre; 
1.6–17.5 in the Balearic Islands) and higher for men than 
for women in Catalonia and Navarre (online supplemen-
tary file table S2–S7). The overall trend of new smoker incidence 
rates decreased significantly in Catalonia (AAPC=−10.39) 
and Navarre (AAPC=−9.49); additionally, the decline was 
similar for men and women. In contrast, the overall trend 
remained stable in the Balearic Islands despite a decrease 
until 2012.4 (APC=−46.20) and a considerable increase 
from 2012.4 to 2013.4 (APC=1054.2) (tables 2, 3 and 4, 
online supplementary file figure S2).
The overall standardised new ex-smoker incidence rates per 
10 000 inhabitants showed higher values in Catalonia 
(range: 110.7–317.6) than in Navarre (range: 48.6–181.0) 
and the Balearic Islands (range: 93.7–188.1) (online 
supplementary file table S2–S7). The overall trend of new 
ex-smoker incidence rates showed a significant decrease in 
Catalonia (AAPC=−7.27) and especially in the Balearic 
Islands (AAPC=−11.24). This downward trend was higher 
for men than for women in Catalonia and the Balearic 
Islands (tables 2, 3 and 4, online supplementary file 
figure S2).
The overall standardised ex-smoker relapse incidence rates 
per 10 000 inhabitants presented higher values in the 
Balearic Islands (range: 103.9–576.6) than in Catalonia 
(range: 70.7–334.5) and Navarre (range: 58.6–230.3) 
(online supplementary file table S2–S7). The overall 
trend of ex-smoker relapse incidence rates showed significant 
increases in Catalonia (AAPC=18.60), particularly in 
women (AAPC=14.56), although a decrease from 2008.1 
to 2012.3 was observed (APC=−8.40). In contrast, Navarre 
showed significant decreases (AAPC=−11.42)(tables 2, 3 
and 4, online supplementary file figure S2).
DIsCussIOn
The previous implementation of the partial Spanish SFL 
could account for the low effectiveness of the comprehen-
sive SFL observed in this study. A significant downward 
trend of smoker prevalence rates, higher in men than in 
women, was found in the three regions throughout the 
study period. Correspondingly, the trend of ex-smoker 
prevalence rates increased in the three regions, partic-
ularly in Navarre and during the period 2008.1–2008.2 
in Catalonia, 2008.1–2008.4 in Navarre, and 2010.2–
2012.2 in the Balearic Islands. Even though the stan-
dardised ex-smoker prevalence rate was higher for men, 
the increase in the trend of ex-smoker prevalence rate 
was higher in women in the three regions. The overall 
trends of new smoker incidence rates decreased signifi-
cantly in Catalonia and Navarre and were similar for men 
and women. Also, the overall trends of new ex-smokers 
decreased significantly in Catalonia and the Balearic 
Islands, particularly for men. In addition, the overall 
trends of ex-smoker relapse increased in Catalonia and 
decreased in Navarre, more for women than for men in 
both cases.
The trends of smoker prevalence declined throughout 
the study and no changes were observed after the imple-
mentation of the comprehensive SFL. Indeed, the most 
significant decrease begins in 2010 in Catalonia (third 
quarter) and the Balearic Islands and in 2008 in Navarre, 
prior to the implementation of the comprehensive SFL 
(1 January 2011). However, the trend in Catalonia shows 
a drop in the prevalence rate of smokers around the time 
of the implementation of the law. In contrast, trends in 
Navarre and the Balearic Islands show a more progres-
sive decline. Comparisons are difficult due to the lack 
of studies on smoking prevalence and incidence from a 
PHC perspective and because some studies evaluate the 
impact of SFL on smoking prevalence with surveys that 
Table 1 Characteristics of the cohort study population by region at the onset of the study (2008 in Catalonia and Navarre, 
2010 in the Balearic Islands)
Catalonia
n = 1 41 071 
Navarre
n = 73 644 
Balearic Islands
n = 1 78 251 
Age (years), SD 50.37 (17.23) 54.04 (18.26) 47.65 (17.56)
Sex (female), number (%) 72 340 (51.28) 37 898 (51.46) 94 164 (52.83)












Patients belonged to 22 primary healthcare teams in each region.
Abbreviations: SD, standard deviation; IQR, interquartile range. 
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use different methodologies. Two studies that analysed 
data from surveys of the general population19 20 did not 
find a significant decrease in the prevalence of smokers 
after the Spanish comprehensive law. In contrast, Lidón 
et al24 showed that after the implementation of both 
Spanish SFLs, a significant decrease was observed in the 
smoking prevalence (from 34.5% to 26.1%, prevalence 
ratio=0.76, p<0.001) of people 16 years of age and older 
living in Barcelona surveyed in 2004–2005 and followed up 
in 2013–2014. In addition, National Health Survey data 
from the 1987–2005 period revealed an annual average 
absolute decline of 1.0% in the prevalence of male 
smokers, whereas women showed an annual average 
absolute increase in prevalence of 0.2%. Between 2006 
and 2014, the prevalence of smokers declined annually by 
0.7% in men and 0.5% in women.23 Although the values 
of the current study are higher, the steeper decline in the 
prevalence of smokers in men agree with these data.23 
Also, one study that estimated the effect of the Spanish 
SFL for the 2012–2025 period predicted a decrease in 
smoking prevalence in all age groups and for both sexes, 
except for women aged 40–64 years.30
Concomitantly with the decline in the prevalence 
trends in smokers, a constant increase of prevalence 
trends in ex-smokers was observed in the three regions. 
Other studies failed to note a significant change in the 
prevalence of ex-smokers after the comprehensive SFL: 
a difference of only 0.3% between 2007 and 2 011,20 and 
a non-significant increase of 3.3% between 2006 and 
2011.19 In agreement with a recent evidence review,23 we 
observed a higher increase in the trend of ex-smokers 
prevalence in women. This review showed that the rate 
of smoking cessation in men increased 0.9% annually 
during the 1987–2014 period, and 1.5% in women after 
the partial SFL came into force. The later incorpora-
tion of women to smoking might explain these gender 
differences. We should underscore that other studies 
that use health surveys as an information source have a 
higher prevalence of ex-smokers than the prevalence we 
obtained in this study, especially for Navarre and the Bale-
aric Islands.31 This discrepancy could be explained by the 
misclassification of long-term ex-smokers as non-smokers 
during the process of computerisation of medical records 
in the cases where the smoking habit was not sufficiently 
investigated.32
We observed a gradual decline in the new smoker inci-
dence trends in Catalonia and Navarre throughout the 
study period, whereas incidence trends remained stable 
in the Balearic Islands (possibly due to the shorter study 
period or lower rates). A review by Wilson et al33 of two 
studies that evaluated smoking initiation reported mixed 
results, while Guerrero et al34 concluded that the Spanish 
partial SFL had no effect on new smokers in 2009. In 
contrast, Pinilla and Abásolo35 observed a 6% decrease in 
the rate of smoking initiation among young people after 
the implementation of the same law, with a more positive 
impact in higher socioeconomic strata. We have not found 
studies that evaluate the impact of the comprehensive 
SFL on the incidence of new smokers. However, our data 
show a continuation in the trend observed in Pinilla’s 
study35 on the impact of the partial law.
The incidence trend in new ex-smokers declined grad-
ually throughout the study period in Catalonia and the 
Balearic Islands. While the literature to date lacks data on 
the effect of the SFL on the incidence of new ex-smokers, 
it provides some information on prevalence. In this 
respect, one study on the Spanish partial SFL observed 
an increase of 8% between 2006 and 2011 in the rate of 
cessation among adult smokers (age 21 years and older) 
according to data from the National Health Survey.35 In 
Luxembourg, smoking cessation attributed to the SFL 
was higher among daily smokers with a higher socio-
economic status.8 In our cohort, we observed apparent 
random increases and declines in the adjusted rates in 
the three regions throughout the study.
The incidence trend in ex-smoker relapses increased in 
Catalonia and declined in Navarre constantly throughout 
the whole period, particularly for women, but the overall 
trend remained stable in the Balearic islands (most likely 
because of the shorter study period). However, the liter-
ature presents conflicting results regarding smoking 
relapse. One study on the partial Spanish SFL observed 
that most people who had succeeded in giving up smoking 
in 2006 had not relapsed by 2009.34 On the other hand, 
a quasi-experimental study conducted in USA observed 
that relapse was similar between employees in workplaces 
with SFL and employees where smoking was permitted.36 
In contrast, Shang found that comprehensive SFL in bars 
significantly deters smoking relapse among people aged 
21 years and older.37 According to Buczkowski et al,38 the 
main reasons for relapse are stress, missing the pleasure 
obtained from smoking and the smoking environment. 
Other factors not analysed in our study that might influ-
ence relapse rates could explain the variations between 
regions, for instance living with other smokers, being 
enrolled in work or clinics cessation programmes,39 or 
the region-specific complementary measures to the SFL 
(for instance, Foral Law 6/2003,40  of smoking preven-
tion, protection from secondhand tobacco smoke and 
promotion of health with regard to smoking in Navarre). 
In addition, we should consider the impact of the finan-
cial crisis during the study period and the subsequent 
increase of anxiety and depression in the population.41 In 
this respect, Navarre was the region with the lowest unem-
ployment rate in Spain according to the 2010 Economi-
cally Active Population Survey (unemployment of 11.6% 
in Navarre, versus 18.0% in Catalonia and 22.2% in the 
Balearic Islands). According to the 2009 European Health 
Survey in Spain, these unemployment figures correlate 
with the prevalence of chronic depression, which was of 
3.4% in Navarre versus 5.4% in Catalonia and 7.0% in the 
Balearic Islands.
The SFL is a keystone of the WHO Framework Conven-
tion on Tobacco Control and the MPOWER policy 
package (M=Monitor; P=Protect; O=Offer; W=Warm; 
E=Enforce; R=Raise).42 The enforcement of Laws 28/2005 
 on N
ovem









pen: first published as 10.1136/bm





10 Pons-Vigués M, et al. BMJ Open 2019;9:e020120. doi:10.1136/bmjopen-2017-020120
Open access 
and 42/2010 have significantly advanced smoking control 
in Spain, in particular the ‘Protect people from tobacco’ 
strategy. However, the remaining MPOWER strategies 
have been patchily implemented and require further 
development.23 On balance, a combination of specific, 
feasible, pragmatic, sufficiently funded policies and inter-
ventions aimed at populations and individuals is essential 
to achieve progress regarding smoking behaviour.
limitations and strengths of the study
It is important to take into account that other than the 
law, the pattern of tobacco consumption is influenced by 
factors such as health interventions, level of education, 
age, civil status, having children and being unemployed.43 
However, this study only considered age, sex, number of 
health problems and number of PHC visits since other 
variables were not available. In addition, many patients 
were excluded from the study because of lack of baseline 
data on smoking (missing data are a common problem in 
studies based on EHR). In order to prevent bias caused 
by improved smoking records, we excluded the cases 
with no information at the beginning of the study. The 
selection criteria and the longitudinal design aimed to 
maximise the internal validity of the study. Moreover, 
young people might be under-represented due to their 
lower use of PHC services. On the other hand, 70% of the 
population attends PHC services at least once a year and 
smokers attend more frequently than no smokers.44 In 
view of the limited length of the study period, particularly 
in the Balearic Islands, we consider these results a first 
approximation to be succeeded by follow-up research. 
We should underscore that rather than just comparing 
two different periods, Joinpoint analysis evaluates longitu-
dinal trends, thus producing a more accurate assessment. 
The following characteristics of the study were taken into 
consideration: scarcity of data prior to the implementa-
tion of the SFL; delayed changes in smoking status; possi-
bility of detecting more than one change in smoking 
trends; and influence of unanticipated factors. While 
other statistical models could have been used, we believe 
that Joinpoint is a suitable method to achieve the study 
objectives, as shown in previous studies.45–47
This study provides useful data on the impact of the 
Spanish comprehensive SFL on adult smoking behaviour 
in PHC patients. It is crucial to analyse the consequences 
of a public health law on PHC users. PHC has a pivotal 
role in smoking cessation because it is the gatekeeper of 
the health services; it is accessible and provides continuity 
of care to smokers.48 We should also highlight that this 
study includes the evaluation of novel variables such as 
incidence of new smokers, new ex-smokers and ex-smoker 
relapse, which we consider of great relevance in relation 
to PHC interventions for smoking cessation. Used as 
a research tool, EHRs portray real life conditions and 
provide comprehensive, long-term health histories from a 
large population sample, ensure high representativeness 
and external validity, and minimise potential recall bias. 
The results are only generalisable to PHC users. To our 
knowledge, this study is among the first to show quarterly 
data from EHRs.
COnClusIOns
The introduction of the Spanish comprehensive SFL (Law 
42/2010) does not significantly modify incidence and 
prevalence trends of smoking behaviour in PHC adult 
patients in Catalonia, Navarre and the Balearic Islands. 
The impact of the comprehensive SFL might have been 
lessened by the effect of the previous implementation 
of the partial SFL (Law 28/2005). The current article 
provides baseline data for future research into the effec-
tiveness of this law. In addition to specific factors associ-
ated with smoking behaviour (such as the price of a pack 
of cigarettes or funding of smoking cessation services), 
future studies should consider socioeconomic status and 
age groups.
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